Copyright West LLC. Minimum 15 minutes delayed.
–
Summary ToggleIntellia Therapeutics Reports Progress on CRISPR/Cas9 AML Cancer Therapy Using Proprietary Cell Engineering Process at the 23rd Annual Meeting of the American Society of Gene and Cell Therapy
Jun 3, 2020
Intellia Therapeutics, Inc. at the Jefferies Global Healthcare Conference
